SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-17-007951
Filing Date
2017-07-18
Accepted
2017-07-18 17:31:28
Documents
4
Period of Report
2017-07-18
Effectiveness Date
2017-07-18

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 840838
2 GRAPHIC image_001.jpg GRAPHIC 4655
3 GRAPHIC image_007.jpg GRAPHIC 144619
4 GRAPHIC image_008.jpg GRAPHIC 133761
  Complete submission text file 0001493152-17-007951.txt   1232072
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-27072 | Film No.: 17970209
SIC: 2836 Biological Products, (No Diagnostic Substances)